These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27765504)

  • 1. Cochlearoids F-K: Phenolic meroterpenoids from the fungus Ganoderma cochlear and their renoprotective activity.
    Wang XL; Zhou FJ; Dou M; Yan YM; Wang SM; Di L; Cheng YX
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5507-5512. PubMed ID: 27765504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective phenolic meroterpenoids from the mushroom Ganoderma cochlear.
    Wang XL; Wu ZH; Di L; Zhou FJ; Yan YM; Cheng YX
    Phytochemistry; 2019 Jun; 162():199-206. PubMed ID: 30947089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective meroterpenoids from the fungus Ganoderma cochlear.
    Wang XL; Wu ZH; Di L; Zhou FJ; Yan YM; Cheng YX
    Fitoterapia; 2019 Jan; 132():88-93. PubMed ID: 30521858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (±) Cochlearoids N-P: three pairs of phenolic meroterpenoids from the fungus Ganoderma cochlear and their bioactivities.
    Qin FY; Yan YM; Tu ZC; Cheng YX
    J Asian Nat Prod Res; 2019 Jun; 21(6):542-550. PubMed ID: 29985069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (±)-Gancochlearols J - N, renoprotective meroterpenoids from Ganoderma cochlear.
    Meng XH; Qin FY; Jiang XT; Li Y; Cheng YX
    Bioorg Chem; 2021 Jul; 112():104950. PubMed ID: 33962091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlearols A and B, polycyclic meroterpenoids from the fungus Ganoderma cochlear that have renoprotective activities.
    Dou M; Di L; Zhou LL; Yan YM; Wang XL; Zhou FJ; Yang ZL; Li RT; Hou FF; Cheng YX
    Org Lett; 2014 Dec; 16(23):6064-7. PubMed ID: 25402560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meroterpenoids from the fruiting bodies of Ganoderma theaecolum.
    Luo Q; Tu ZC; Yang ZL; Cheng YX
    Fitoterapia; 2018 Mar; 125():273-280. PubMed ID: 29378219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiro Meroterpenoids from Ganoderma applanatum.
    Luo Q; Wei XY; Yang J; Luo JF; Liang R; Tu ZC; Cheng YX
    J Nat Prod; 2017 Jan; 80(1):61-70. PubMed ID: 27996259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective ganodermaones A and B with rearranged meroterpenoid carbon skelotons from Ganoderma fungi.
    Zhang JJ; Qin FY; Meng XH; Yan YM; Cheng YX
    Bioorg Chem; 2020 Jul; 100():103930. PubMed ID: 32450386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australeols A-F, neuroprotective meroterpenoids from Ganoderma australe.
    Zhang JJ; Dong Y; Qin FY; Cheng YX
    Fitoterapia; 2019 Apr; 134():250-255. PubMed ID: 30825574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meroterpenoid enantiomers from Ganoderma sinensis.
    Cao WW; Luo Q; Cheng YX; Wang SM
    Fitoterapia; 2016 Apr; 110():110-5. PubMed ID: 26947249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Petchienes A-E, Meroterpenoids from Ganoderma petchii.
    Gao QL; Guo PX; Luo Q; Yan H; Cheng YX
    Nat Prod Commun; 2015 Dec; 10(12):2019-22. PubMed ID: 26882654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (±) Gancochlearols A and B: cytotoxic and COX-2 inhibitory meroterpenoids from
    Qin FY; Yan YM; Tu ZC; Cheng YX
    Nat Prod Res; 2020 Aug; 34(16):2269-2275. PubMed ID: 30518262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meroterpenoid dimers from Ganoderma cochlear and their cytotoxic and COX-2 inhibitory activities.
    Qin FY; Yan YM; Tu ZC; Cheng YX
    Fitoterapia; 2018 Sep; 129():167-172. PubMed ID: 29969649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zizhines G-O, AchE inhibitory meroterpenoids from Ganoderma sinensis.
    Luo Q; Cao WW; Wu ZH; Wang SM; Cheng YX
    Fitoterapia; 2019 Apr; 134():411-416. PubMed ID: 30902752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe.
    Guo JC; Yang L; Ma QY; Ge YZ; Kong FD; Zhou LM; Fei Zhang ; Xie QY; Yu ZF; Dai HF; Zhao YX
    Bioorg Chem; 2021 Dec; 117():105448. PubMed ID: 34736135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gancochlearols E - I, meroterpenoids from Ganoderma cochlear against COX-2 and triple negative breast cancer cells and the absolute configuration assignment of ganomycin K.
    Li YP; Jiang XT; Qin FY; Zhang HX; Cheng YX
    Bioorg Chem; 2021 Apr; 109():104706. PubMed ID: 33607360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five undescribed meroterpenoids from Ganoderma lucidum and their inhibitory activities against renal fibrosis.
    Li D; Gao Q; Cheng YX; Luo Q
    Fitoterapia; 2024 Jul; 176():106031. PubMed ID: 38768793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meroterpenoids and alkaloids from
    Zhang JJ; Dong Y; Qin FY; Yan YM; Cheng YX
    Nat Prod Res; 2021 Oct; 35(19):3226-3232. PubMed ID: 31741407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racemic meroterpenoids from Ganoderma cochlear.
    Peng X; Wang X; Chen L; Yang H; Li L; Lu S; Zhou L; Qiu M
    Fitoterapia; 2018 Jun; 127():286-292. PubMed ID: 29540310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.